4//SEC Filing
Newell Joe 4
Accession 0001567619-21-020653
CIK 0001604464other
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 4:15 PM ET
Size
11.0 KB
Accession
0001567619-21-020653
Insider Transaction Report
Form 4
Newell Joe
Chief Tech. Operations Officer
Transactions
- Sale
Common Stock
2021-11-15$17.71/sh−7,000$124,004→ 116,429 total - Exercise/Conversion
Common Stock
2021-11-15$12.15/sh+3,500$42,525→ 123,429 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-11-15−2,792→ 32,083 totalExercise: $12.15Exp: 2030-02-28→ Common Stock (2,792 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-11-15−708→ 9,917 totalExercise: $12.15Exp: 2030-02-28→ Common Stock (708 underlying)
Footnotes (3)
- [F1]Transaction pursuant to Rule 10b5-1 Plan adopted September 14, 2020.
- [F2]The price in Column 4 is a weighted average sale price. The prices actually received ranged from $17.62 to $17.85. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]1/48th of the shares subject to the stock option vest and become exercisable each month with the initial installment vesting on April 1, 2020, subject to the reporting person's continuous service.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001702457
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 4:15 PM ET
- Size
- 11.0 KB